AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Adagio Medical Statistics
Share Statistics
Adagio Medical has 14.54M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 14.54M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 76 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 11.54K, so 0.08% of the outstanding shares have been sold short.
Short Interest | 11.54K |
Short % of Shares Out | 0.08% |
Short % of Float | 0.08% |
Short Ratio (days to cover) | 0.85 |
Valuation Ratios
The PE ratio is -3.18 and the forward PE ratio is null.
PE Ratio | -3.18 |
Forward PE | null |
PS Ratio | 403.86 |
Forward PS | null |
PB Ratio | -2.88 |
P/FCF Ratio | -4.66 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Adagio Medical Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11, with a Debt / Equity ratio of -0.95.
Current Ratio | 0.11 |
Quick Ratio | 0.04 |
Debt / Equity | -0.95 |
Total Debt / Capitalization | -1.74K |
Cash Flow / Debt | -0.64 |
Interest Coverage | -16.84 |
Financial Efficiency
Return on equity (ROE) is 0.91% and return on capital (ROIC) is 1296.61%.
Return on Equity (ROE) | 0.91% |
Return on Assets (ROA) | -5.59% |
Return on Capital (ROIC) | 1296.61% |
Revenue Per Employee | 3.45K |
Profits Per Employee | -438.46K |
Employee Count | 87 |
Asset Turnover | 0.04 |
Inventory Turnover | 0.39 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -0.1, so Adagio Medical 's price volatility has been lower than the market average.
Beta | -0.1 |
52-Week Price Change | null% |
50-Day Moving Average | 2.22 |
200-Day Moving Average | null |
Relative Strength Index (RSI) | 35.94 |
Average Volume (20 Days) | 414.94K |
Income Statement
In the last 12 months, Adagio Medical had revenue of 300.00K and earned -38.15M in profits. Earnings per share was -0.16.
Revenue | 300.00K |
Gross Profit | -1.01M |
Operating Income | -27.94M |
Net Income | -38.15M |
EBITDA | -27.41M |
EBIT | -27.94M |
Earnings Per Share (EPS) | -0.16 |
Balance Sheet
The company has 1.38M in cash and 39.95M in debt, giving a net cash position of -38.57M.
Cash & Cash Equivalents | 1.38M |
Total Debt | 39.95M |
Net Cash | -38.57M |
Retained Earnings | -135.21M |
Total Assets | 107.20M |
Working Capital | 27.11M |
Cash Flow
In the last 12 months, operating cash flow was -25.65M and capital expenditures -340.00K, giving a free cash flow of -25.99M.
Operating Cash Flow | -25.65M |
Capital Expenditures | -340.00K |
Free Cash Flow | -25.99M |
FCF Per Share | -1.94 |
Margins
Gross margin is -33.53K%, with operating and profit margins of -931.40K% and -1.27M%.
Gross Margin | -33.53K% |
Operating Margin | -931.40K% |
Pretax Margin | -1.27M% |
Profit Margin | -1.27M% |
EBITDA Margin | -9.14K% |
EBIT Margin | -9.31K% |
FCF Margin | -8.66K% |
Dividends & Yields
ADGM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -14.29% |
FCF Yield | -159.66% |
Analyst Forecast
Currently there are no analyst rating for ADGM.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -0.11 |
Piotroski F-Score | 2 |